Goodson AG, Florell SR, Boucher KM, Grossman D
Articles discussing the use of GLP-1 agonists for indications other than skin conditions were excluded
Because peptides sit inside a full functional medicine clinic, your plan connects to hormone, weight, and longevity care under one team, so the pieces work together
Sensitivity analyses To verify the robustness of the data, we performed three sensitivity analyses: First, in order to account for potential unmeasured confounding by including an active comparator, we evaluated the risk of incident NAION in persons treated with sodium-glucose transport protein 2 (SGLT2) inhibitors (ATC: A10BK01 [ n = 84,283], A10BK02 [ n = 3048], A10BK03 [ n = 85,892], A10BK04 [ n = 96]) versus once-weekly semaglutide with or without redemption of prescriptions for SGLT2 inhibitors
[12] Pati, S., Irfan, W., Jameel, A., Ahmed, S., & Shahid, R
Ethics declarations Competing interests The authors declare that the Monell Chemical Senses Center has filed a patent application related to potential therapeutic compounds
/assets/images/provider/photos/2775905.jpeg)
